We are live on
!
Find out more
AIM
Aigen Investment Management Portfolio holdings
AUM
$389M
1-Year Est. Return
16.77%
This Fund
S&P 500
This Quarter
Est. Return
+3.44%
1 Year Est. Return
+16.77%
3 Year Est. Return
+38.84%
5 Year Est. Return
+26.96%
10 Year Est. Return
–
AUM
$677M
AUM Growth
-$50M
(-6.9%)
Cap. Flow
-$67.1M
Cap. Flow
% of AUM
-9.92%
Top 10 Holdings %
Top 10 Hldgs %
11.02%
Holding
1,031
New
439
Increased
126
Reduced
146
Closed
320
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$10.2M |
| 2 |
Kimberly-Clark
KMB
|
+$8.57M |
| 3 |
SBA Communications
SBAC
|
+$7.81M |
| 4 |
PG&E
PCG
|
+$5.73M |
| 5 |
Advance Auto Parts
AAP
|
+$5.62M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$15.6M |
| 2 |
Pfizer
PFE
|
+$14.6M |
| 3 |
Dominion Energy
D
|
+$13.4M |
| 4 |
Johnson & Johnson
JNJ
|
+$12.9M |
| 5 |
Cadence Design Systems
CDNS
|
+$9.77M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 19.25% |
| 2 | Technology | 16.12% |
| 3 | Industrials | 11.55% |
| 4 | Financials | 11.01% |
| 5 | Healthcare | 10.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
BioCryst Pharmaceuticals
BCRX
$2.4B
| $551K | 0.08% |
78,295
+35,772
| +84% | +$287K |
|
|
BPMC
327
DELISTED
Blueprint Medicines
BPMC
| $546K | 0.08% |
+8,635
| New | +$469K |
|
328
Hanover Insurance
THG
$7.98B
| $545K | 0.08% |
+4,820
| New | +$571K |
|
329
Dick's Sporting Goods
DKS
$18.7B
| $539K | 0.08% |
4,076
-14,723
| -78% | -$2.01M |
|
330
Lincoln National
LNC
$8.81B
| $539K | 0.08% |
20,909
-34,355
| -62% | -$754K |
|
331
Stewart Information Services
STC
$2.08B
| $537K | 0.08% |
13,047
-439
| -3% | -$18.6K |
|
332
Progyny
PGNY
$2.2B
| $536K | 0.08% |
+13,629
| New | +$492K |
|
333
Portillo's
PTLO
$321M
| $534K | 0.08% |
23,701
+10,849
| +84% | +$226K |
|
334
Simpson Manufacturing
SSD
$8.16B
| $534K | 0.08% |
3,854
-1,075
| -22% | -$132K |
|
335
Columbia Sportswear
COLM
$2.94B
| $532K | 0.08% |
6,888
-15,788
| -70% | -$1.27M |
|
336
Lam Research
LRCX
$390B
| $530K | 0.08% |
+8,250
| New | +$465K |
|
337
Lennox International
LII
$15.2B
| $529K | 0.08% |
+1,623
| New | +$459K |
|
|
IPG
338
DELISTED
Interpublic Group of Companies
IPG
| $527K | 0.08% |
+13,659
| New | +$515K |
|
339
Factset
FDS
$10.2B
| $525K | 0.08% |
+1,310
| New | +$528K |
|
340
Madrigal Pharmaceuticals
MDGL
$11.8B
| $524K | 0.08% |
2,270
-862
| -28% | -$233K |
|
341
argenx
ARGX
$54.1B
| $523K | 0.08% |
1,343
-2,126
| -61% | -$836K |
|
342
ASML
ASML
$669B
| $523K | 0.08% |
722
-7,354
| -91% | -$5M |
|
|
SF
343
Stifel
SF
$12.6B
| $516K | 0.08% |
+12,974
| New | +$506K |
|
344
Amphastar Pharmaceuticals
AMPH
$916M
| $510K | 0.08% |
8,868
+1,069
| +14% | +$47.4K |
|
345
Sarepta Therapeutics
SRPT
$1.77B
| $507K | 0.07% |
4,428
-8,428
| -66% | -$1.09M |
|
346
Teekay Tankers
TNK
$2.68B
| $505K | 0.07% |
13,212
-2,673
| -17% | -$104K |
|
347
Comcast
CMCSA
$90B
| $501K | 0.07% |
+12,058
| New | +$479K |
|
348
Diageo
DEO
$53.6B
| $499K | 0.07% |
2,877
-2,309
| -45% | -$412K |
|
349
WillScot Mobile Mini Holdings
WSC
$4.41B
| $498K | 0.07% |
+10,425
| New | +$466K |
|
350
Honeywell
HON
$78B
| $497K | 0.07% |
2,539
-30,368
| -92% | -$5.64M |
|
Similar funds
SA
WCM
PFPGI
PG
SI
MA
TCM
HBWM
Aigen Investment Management's Q2 2023 Portfolio in Review
As of Q2 2023, Aigen Investment Management held 1,031 positions worth $677M, down 6.9% from $727M the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Aigen Investment Management withdrew a net $67.1M in Q2 2023, closing 320 positions and reducing 146 holdings. Its most notable exit was Pfizer, an estimated $14.6M position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 19% of assets, down from 20% a quarter earlier, followed by Technology and Industrials.
Against the trend, Aigen Investment Management opened a new position in Apple worth $11.4M.
- Aigen Investment Management's largest Q2 2023 buy was Apple: 58,654 shares worth $11.4M.
- Aigen Investment Management added most to Advance Auto Parts in Q2 2023, an estimated $5.62M increase.
- Aigen Investment Management's biggest Q2 2023 reduction was Broadcom, cutting an estimated $15.6M.
- Aigen Investment Management fully exited Pfizer in Q2 2023, selling an estimated $14.6M.
- Aigen Investment Management's ten largest holdings make up 11% of its $677M portfolio in Q2 2023.
- Aigen Investment Management opened 439 new positions and closed 320 in Q2 2023.
- Aigen Investment Management's portfolio value fell 6.9% quarter-over-quarter to $677M.
Based on Aigen Investment Management's 13F filing for Q2 2023, filed 14 Aug 2023.